BridgeBio Pharma's total assets for Q2 2025 were $1.08B, an increase of 22.52% from the previous quarter. BBIO total liabilities were $2.86B for the fiscal quarter, a 13.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.